Abstract:
Methods and compositions for preventing or treating an anthrax toxin mediated disease condition in an individual are provided. Aspects of the subject methods include administering to a subject an effective amount of an agent that inhibits cellular entry of an anthrax toxin mediated by complexes comprising a beta1 integrin subunit. Also provided are active agents suitable for use in the subject methods, as well as pharmaceutical preparations thereof and kits thereof. Methods of screening candidate agents for anti-toxin activity are also provided.
Abstract:
The present invention includes hybridoma cell lines and monoclonal antibodies that bind to the anthrose tetrasaccharide of Bacillus anthracis and methods using said antibodies.
Abstract:
Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a toxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated toxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed, and antibodies specifically binding to those amino acid sequences. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO :21-32, or the nucleotide sequence set forth in SEQ ID NO: 1-20, as well as variants and fragments thereof.
Abstract translation:提供了赋予细菌,植物,植物细胞,组织和种子的杀虫活性的组合物和方法。 提供了包含毒素多肽的编码序列的组合物。 编码序列可用于DNA构建体或表达盒中,用于在植物和细菌中转化和表达。 组合物还包括转化的细菌,植物,植物细胞,组织和种子。 特别地,提供了分离的毒素核酸分子。 另外,包括对应于多核苷酸的氨基酸序列,以及与这些氨基酸序列特异性结合的抗体。 特别地,本发明提供了分离的核酸分子,其包含编码SEQ ID NO:21-32所示的氨基酸序列的核苷酸序列或SEQ ID NO:1-20所示的核苷酸序列,以及变体和 片段。
Abstract:
Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed, and antibodies specifically binding to those amino acid sequences. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO: 61-121 and 133-141, or the nucleotide sequence set forth in SEQ ID NO: 1-60, 124-132, and 142-283, as well as variants and fragments thereof.
Abstract translation:提供了赋予细菌,植物,植物细胞,组织和种子的杀虫活性的组合物和方法。 提供了包含δ-内毒素多肽的编码序列的组合物。 编码序列可用于DNA构建体或表达盒中,用于在植物和细菌中转化和表达。 组合物还包括转化的细菌,植物,植物细胞,组织和种子。 特别地,提供了分离的δ-内毒素核酸分子。 另外,包括对应于多核苷酸的氨基酸序列,以及与这些氨基酸序列特异性结合的抗体。 特别地,本发明提供了分离的核酸分子,其包含编码SEQ ID NO:61-121和133-141所示氨基酸序列的核苷酸序列或SEQ ID NO:1-60,124 -132和142-283,以及其变体和片段。
Abstract:
The present invention concerns methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. The invention provides methods and compositions for stimulating an immune response against the bacteria. In certain embodiments, the methods and compositions involve an Eap, Emp and/or AdsA amino acid sequence, or an agent that binds and inhibits the same.
Abstract:
The invention relates to a G-class immunoglobulin (IgG) directed against the protective antigen (PA) of the anthrax toxin, that includes: a light-chain variable region including an amino-acid sequence that is at least 90% identical in terms of amino-acids with the sequence SEQ ID N °1 as defined in the description; and a heavy-chain variable region including an amino acid sequence that is at least 90% identical in terms of amino-acids with the sequence SEQ ID N °2 as defined in the description; characterised in that it consists of an IgG1 or an IgG2.
Abstract translation:本发明涉及针对所述炭疽毒素的保护性抗原(PA)的G级免疫球蛋白(IgG),其包括:轻链可变区,其包含与SEQ ID NO:1至少90%相同的氨基酸序列 具有如说明书中定义的序列SEQ ID NO:1的氨基酸; 和重链可变区,其包含氨基酸序列,氨基酸序列与描述中定义的序列SEQ ID N°2的氨基酸相同; 其特征在于其由IgG1或IgG2组成。
Abstract:
The present invention relates to monoclonal antibodies that bind or neutralize anthrax lethal factor (LF), edema factor (EF), and/or protective antigen (PA). The invention provides such antibodies, fragments of such antibodies retaining anthrax toxin-binding ability, fully human or humanized antibodies retaining anthrax toxin-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.
Abstract:
Compounds and compositions containing poly-?-D,L-glutamic acid (PGA) moieties and their use in preventing or treating nosocomial infections caused by Staphylococcus and Bacillus are disclosed.